Literature DB >> 24614842

Second BMT for thalassemia major using CY post transplant.

N Yaqub1, S Khalid2, F Itrat1, A Khan1, S K Gilani1, M E Missiry2, M H Hussain2, C Uderzo2, L Faulkner2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24614842     DOI： 10.1038/bmt.2014.36

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia--the role of busulfan pharmacokinetics in determining outcome.

Authors:  M Chandy; P Balasubramanian; S V Ramachandran; V Mathews; B George; D Dennison; R Krishnamoorthy; A Srivastava
Journal:  Bone Marrow Transplant       Date:  2005-11       Impact factor: 5.483

2.  Second bone marrow transplantation for patients with thalassemia: risks and benefits.

Authors:  Polina Stepensky; Reuven Or; Michael Y Shapira; Shoshana Revel-Vilk; Jerry Stein; Igor B Resnick
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

3.  French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions.

Authors:  Claire Galambrun; Corinne Pondarré; Yves Bertrand; Anderson Loundou; Pierre Bordigoni; Pierre Frange; Patrick Lutz; Valérie Mialou; Hervé Rubie; Gérard Socié; Pascale Schneider; Françoise Bernaudin; Catherine Paillard; Gérard Michel; Catherine Badens; Isabelle Thuret
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-11       Impact factor: 5.742

4.  HLA-matched sibling stem cell transplantation in children with β-thalassemia with anti-thymocyte globulin as part of the preparative regimen: the Greek experience.

Authors:  E Goussetis; I Peristeri; V Kitra; G Vessalas; A Paisiou; M Theodosaki; E Petrakou; M N Dimopoulou; S Graphakos
Journal:  Bone Marrow Transplant       Date:  2011-11-14       Impact factor: 5.483

5.  HLA-matched sibling bone marrow transplantation for β-thalassemia major.

Authors:  Mitchell Sabloff; Mammen Chandy; Zhiwei Wang; Brent R Logan; Ardeshir Ghavamzadeh; Chi-Kong Li; Syed Mohammad Irfan; Christopher N Bredeson; Morton J Cowan; Robert Peter Gale; Gregory A Hale; John Horan; Suradej Hongeng; Mary Eapen; Mark C Walters
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

6.  High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

Authors:  Leo Luznik; Javier Bolaños-Meade; Marianna Zahurak; Allen R Chen; B Douglas Smith; Robert Brodsky; Carol Ann Huff; Ivan Borrello; William Matsui; Jonathan D Powell; Yvette Kasamon; Steven N Goodman; Allan Hess; Hyam I Levitsky; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
Journal:  Blood       Date:  2010-02-02       Impact factor: 22.113

7.  Hematopoietic stem cell transplantation in thalassemia and sickle cell disease. Unicenter experience in a multi-ethnic population.

Authors:  Marco Marziali; Antonella Isgrò; Javid Gaziev; Guido Lucarelli
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-26       Impact factor: 2.576

8.  Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft.

Authors:  J Gaziev; P Sodani; G Lucarelli; P Polchi; S Marktel; K Paciaroni; M Marziali; A Isgrò; M D Simone; A Roveda; A Montuoro; A Lanti; C Alfieri; G De Angelis; C Gallucci; F Ciceri; M G Roncarolo
Journal:  Bone Marrow Transplant       Date:  2008-06-23       Impact factor: 5.483

9.  Bone marrow transplantation in patients with thalassemia.

Authors:  G Lucarelli; M Galimberti; P Polchi; E Angelucci; D Baronciani; C Giardini; P Politi; S M Durazzi; P Muretto; F Albertini
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

10.  HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

Authors:  Javier Bolaños-Meade; Ephraim J Fuchs; Leo Luznik; Sophie M Lanzkron; Christopher J Gamper; Richard J Jones; Robert A Brodsky
Journal:  Blood       Date:  2012-09-06       Impact factor: 22.113
  10 in total
  1 in total

1.  ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia.

Authors:  Lawrence Faulkner; Cornelio Uderzo; Sadaf Khalid; Priya Marwah; Rajpreet Soni; Naila Yaqub; Samina Amanat; Itrat Fatima; Sarah Khan Gilani; Tatheer Zahra; Stalin Ramprakash; Lallindra Gooneratne; Ruwangi Dissanayake; Senani Williams; Wasantha Rathnayake; Reshma Srinivas; Amit Sedai; Ankita Kumari; Lailith Parmar; Rakesh Dhanya; Rajat Kumar Agarwal
Journal:  Blood Adv       Date:  2017-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.